Search Clinical Pathways
Penicillin Drug Allergy Clinical Pathway — All Settings
The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.
Pulmonary Hypertension Screening in Patients with Bronchopulmonary Dysplasia Clinical Pathway — ICU and Inpatient
Inpatient Clinical Pathway to standardize the process to screen for pulmonary hypertension in infants with Bronchopulmonary Dysplasia (BPD). BPD remains a major source of morbidity and mortality for extremely low birth weight infants.
Emergency Department and Inpatient Mitochondrial Clinical Pathway
This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.
Management of Infants with Lymphatic Disorders Clinical Pathway — Inpatient
This pathway is to be used for infants from birth to 1 year of age, admitted to an intensive care unit, with concern for lymphatic flow disorders without history of surgical/traumatic chylothorax, congenital heart disease, or isolated lymphatic mass.
Prolonged QTc and Prevention of Torsades de Pointes Clinical Pathway — Inpatient
This pathway is intended to support providers caring for children with prolonged QTc identified on ECG. Stratifications of QTC interval measurements provide guidance for care delivery. Recommendations include escalating urgent and emergent support for medical management and continued monitoring for the goal of prevention of Torsades de Pointes.
Post-Cath Pulse Loss Clinical Pathway — ICU and Inpatient
The femoral artery loss clinical pathway outlines the steps to be taken in the case of femoral artery loss in an inpatient setting.
Suspected Acute Heart Failure Clinical Pathway — Emergency Department, ICU and Inpatient
The heart failure clinical pathway outlines the steps to be taken when treating a patient with suspected acute heart failure.
PDA Management in the First Month in High-risk Preterm Neonate Clinical Pathway — ICU and Inpatient
The pathway for management of PDA in the first month of the high risk pre-term neonate outlines the care for high risk neonates while decreasing variability in evaluation and treatment, standardizing echocardiographic readings and decreasing NPO time.
Kawasaki Disease or Incomplete Kawasaki Disease Clinical Pathway — Emergency Department and Inpatient
This pathway is meant to guide the evaluation for patients presenting with symptoms consistent with Kawasaki Disease (KD) or Incomplete Kawasaki Disease and to guide treatment for those diagnosed with KD or Incomplete KD.
Continuous IV Fluid Administration Clinical Pathway — Inpatient
The continuous administration of IV fluids inpatient pathway outlines the algorithm for selecting the initial IV fluid composition and rate when treating a hospitalized patient who requires IV fluids due to dehydration and/or the inability to take 100% of their fluid needs enterally.